CLIA Sceeen In-Viro™
14 Panel CSI Cup, CLIA Screen In-Vitro™ Rapid Drug Test Cup, 25/Box
Bulk discount rates
Below are the available bulk discount rates for each individual item when you purchase a certain amount
Quantity | Per Item |
1 - 3 | $123.75 |
4 - 7 | $117.50 |
8 - 19 | $111.75 |
20+ | $106.25 |
Description
14 Panel CSI Drug Test Cup - CLIA Screen In-Vitro™ Test 25/Case
One of the most popular comprehensive drug testing cups in America, the CSI Cup (CLIA Screen In-Vitro™) Multi-Panel Drug Test Cup is a Highly Reliable, Accurate, No Step, fully integrated self contained multi-drug screening cup. No tipping or turning required. Read results in 5 minutes. The cup is FDA Cleared and CLIA Waived. This cup is a fast visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of multiple drug metabolites at specific cutoff levels in human urine.
Features & Benefits
- CLIA Waived
- FDA 510(K) Approved
- FDA OTC Approved (Over-the-Counter for Home Use)
- Health Canada Approved
- Sold by the Case of 25 tests
- Includes "O-Ring seal" in cap for improved leak resistance
- Click Seal Cap - when you hear the “CLICK” the cup is sealed and the specimen is secured
- No step cup
- Up to 99% Accurate
- Dual scale Temperature Strip verifies if urine is "fresh" and not diluted
- Adheres to the SAMHSA Cutoff Levels
- Immediate Results
- Shelf-life up to 24 months
- New easy to open top for the confirmation lab
Download & Print Reference Materials
CLIA Screen In Vitro CSI Cup (CLIA Waived) Drug Test Package Insert
CLIA Screen In Vitro CSI Cup (CLIA Waived) Drug Test Instruction Sheet
Fourteen Panel Configurations | ||
Item Number | Drugs Tested | Regulatory Approvals |
CSI-CUP-1145 | AMP1000, BAR300, BUP10, BZO300, COC300, MET1000, MDMA500, MOP/OPI300, MTD300, OXY100, PCP25, PPX300, TCA1000, THC50 | • CLIA Waived • FDA 510(k) Cleared • OTC - Over the Counter • Health Canada |
CSI-CUP-1145S | AMP500, BAR300, BUP10, BZO300, COC150, MET500, MDMA500, MOP/OPI300, MTD300, OXY100, PCP25, PPX300, TCA1000, THC50 | • CLIA Waived • FDA 510(k) Cleared • OTC - Over the Counter • Health Canada |
FDA 510(k) CLIA Waived Drug Detection Table in Urine | ||||
Drug Name / Description | Abbreviation | Cutoff | Detection Window* | Certifications / Approvals |
Amphetamine A schedule II drug available by prescription. Acute, higher dosages lead to euphoria, alertness and sense of energy and power. |
AMP | 500 ng/mL or 1000 ng/mL |
2 to 96 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Barbiturates Central nervous system depressants used therapeutically as sedatives hypnotics and anticonvulsants. |
BAR | 300 ng/mL | 2 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Benzodiazepines Frequently prescribed for the symptomatic treatment of anxiety and sleep disorders. |
BZO | 300 ng/mL | 2 to 96 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Buprenorphine / Suboxone A semi-synthetic opioid that has a longer duration of action than morphine and is used to treat moderate to severe pain. |
BUP | 10 ng/mL | 2 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Cocaine A potent central nervous system stimulant and local anesthetic that brings about extreme energy and restlessness. |
COC | 150 ng/mL or 300 ng/mL |
1 to 96 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Methadone Metabolite A controlled substance and is used for detoxification and maintenance of opiate-dependent patients. |
EDDP | 300 ng/mL | 1 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Ecstasy (D.L-Methylenedioxy-Methamphetamine) A designer drug that produces changes in the form of increased sensitivity to light, difficulty in focusing, and blurred vision. |
MDMA | 500 ng/mL | 2 to 96 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Cannabinoids / Marijuana When smoked or orally administered it produces euphoric effects. Users have impaired short term memory and slowed learning. |
THC | 50 ng/mL | 2 Hours to 40 Days | FDA 510k CLIA Waived OTC - Over the Counter |
Methadone A narcotic analgesic prescribed for the management of moderate to severe pain and for treatment of opiate dependence. |
MTD | 300 ng/mL | 3 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Methadone Metabolite A controlled substance and is used for detoxification and maintenance of opiate-dependent patients. |
EDDP | 300 ng/mL | 1 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Methamphetamine An addictive stimulant that affects the central nervous system. Can be taken orally, injected or inhaled. |
mAMP / MET | 500 ng/mL or 1000 ng/mL |
2 hours to 4 days | FDA 510k CLIA Waived OTC - Over the Counter |
Morphine / Opiates A drug derived from the opium poppy, including natural products morphine and codeine, and semi-synthetic drugs such as heroin. |
MOP / OPI | 300 ng/mL or 2000 ng/mL |
2 hours to 3 days | FDA 510k CLIA Waived OTC - Over the Counter |
Oxycodone A schedule II narcotic analgesic widely used in clinical medicine. Similar to morphine, in all respects, including its abuse and dependence. |
OXY | 100 ng/mL | 1 to 48 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Phencyclidine A hallucinogen, also known as Angel Dust, can be used in powder, capsule and tablet form. |
PCP | 25 ng/mL | 4 hours to 14 days | FDA 510k CLIA Waived OTC - Over the Counter |
Propoxyphene A mild narcotic analgesic found in various pharmaceutical preparations, usually as hydrochloride or napsylate salt. |
PPX | 300 ng/mL | 1 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Tricyclic Antidepressants / Nortriptyline Commonly used for treatment of depressive disorders. TCA overdose is the most common cause of death from prescription drugs. |
TCA | 1000 ng/mL | 2 Hours to 40 Days | FDA 510k CLIA Waived OTC - Over the Counter |
* Detection times are not guaranteed. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatogrphy/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. |